Chronic Obstructive Pulmonary Disease in Women: A Biologically Focused Review with a Systematic Search Strategy [Corrigendum]
Han MK. Int J Chron Obstruct Pulmon Dis. 2020;15: 711–721 Page 718, Disclosure section, the disclosure statement was incomplete, the correct statement is “MeiLan K Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/3396059b3ca24ddaac9616940254d02c |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| Sumario: | Han MK. Int J Chron Obstruct Pulmon Dis. 2020;15: 711–721
Page 718, Disclosure section, the disclosure statement was incomplete, the correct statement is “MeiLan K Han reports consulting fees from Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Merck, Mylan and Novartis. She also reports research support from Novartis and Sunovion. Boehringer Ingelheim also supported conduction of the systematic search. The author reports no other conflicts of interest in this work.”
The author apologizes for this error.
Read the original article |
|---|